Skip to main content

Exclusive: Synchron, a rival to Musk's Neuralink, readies large-scale brain implant trial

By Reuters  
   April 09, 2024

Synchron on Monday plans to launch an online registry for patients interested in joining the trial meant to include dozens of participants, and has received interest from about 120 clinical trial centers to help run the study, CEO Thomas Oxley says.

Full story

Get the latest on healthcare leadership in your inbox.